Hepatic Cell News Volume 7.04 | Feb 3 2023

    0
    20








    2023-02-03 | HCN 7.04


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.04 – 3 February, 2023
    TOP STORY

    Targetable Brg1-CXCL14 Axis Contributes to Alcoholic Liver Injury by Driving Neutrophil Trafficking

    The authors reported that Brahma-related gene 1 (Brg1) expression was elevated in mouse models of alcoholic liver disease (ALD), in hepatocytes exposed to alcohol, and in human ALD specimens.
    [EMBO Molecular Medicine]

    Full ArticleGraphical Abstract
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    HERC2 Promotes Inflammation-Driven Cancer Stemness and Immune Evasion in Hepatocellular Carcinoma by Activating STAT3 Pathway

    Researchers sought to identify the new target that was involved in inflammation-related liver tumorigenesis. RNA-sequencing analysis was performed to identify the differential gene expression signature in primary human hepatocytes treated with or without inflammatory stimulus.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Hepatic Phosphatidylcholine Catabolism Driven by PNPLA7 and PNPLA8 Supplies Endogenous Choline to Replenish the Methionine Cycle with Methyl Groups

    The authors highlighted the biological importance of phospholipid catabolism driven by PNPLA8/PNPLA7 in methyl group flux and triglyceride synthesis in the liver.
    [Cell Reports]

    Full Article

    Neprilysin-Dependent Neuropeptide Y Cleavage in the Liver Promotes Fibrosis by Blocking NPY-Receptor 1

    Scientists demonstrated that HSCs are the source of neprilysin (NEP). Neuropeptide Y originated from the splanchnic region and was cleaved by NEP in order to terminate contraction.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Loss of 5-Hydroxymethylcytosine Induces Chemotherapy Resistance in Hepatocellular Carcinoma via the 5-hmC/PCAF/AKT Axis

    Investigators reported that the level of 5-hydroxymethylcytosine (5-hmC) in human HCC tissues was significantly lower than that in adjacent liver tissues, and reduced 5-hmC significantly correlated with malignant phenotypes.
    [Cell Death & Disease]

    Full Article

    Metformin Induces Pyroptosis in Leptin Receptor-Defective Hepatocytes via Overactivation of the AMPK Axis

    Scientists used liver tissue, serum exosomes, and isolated hepatocytes from high-fat diet-induced Zucker diabetic fatty rats and leptin receptor knockout rats to investigate the correlation between hepatic leptin receptor defective and liver damage caused by metformin.
    [Cell Death & Disease]

    Full Article

    A Clinically Feasible Circulating Tumor Cell Sorting System for Monitoring the Progression of Advanced Hepatocellular Carcinoma

    Epithelial cell adhesion molecule/vimentin/Glypican-3 antibody-modified lipid magnetic spheres were used to capture tumor cells with epithelial phenotype in order to capture more circulating tumor cells with a more comprehensive phenotype for monitoring tumor metastasis.
    [Journal of Nanobiotechnology]

    Full Article

    PIMT Regulates Hepatic Gluconeogenesis in Mice

    Investigators observed that the expression of PIMT was upregulated in the livers of short-term fasted and obese mice.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    A Hepatoprotective Role of Peritumoral Non-Parenchymal Cells in Early Liver Tumorigenesis

    Researchers reported a comparative study of hepatic spheroids generated from freshly isolated mouse whole liver cells and hepatocytes.
    [Disease Models & Mechanisms]

    Abstract
    Share your feedback for the chance to win an Uber Eats gift card
    REVIEWS

    Hepatocellular Carcinoma: Molecular Mechanism, Targeted Therapy, and Biomarkers

    The authors explore the molecular mechanism associated with HCC development, summarize targeted therapies for HCC, and discuss potential biomarkers that may drive therapies.
    [Cancer and Metastasis Reviews]

    Abstract
    INDUSTRY AND POLICY NEWS

    Stricter US Guidelines for ‘Gain-of-Function’ Research Are on the Way — Maybe

    A panel of experts joined a meeting of the US National Science Advisory Board of Biosecurity, discussing on issues such as how privately funded risky research would be regulated, the role of research institutions in identifying potentially dangerous research, and much more.
    [Nature]

    Press Release
    FEATURED EVENT

    2nd Next Generation Kinase Inhibitors Summit

    February 22 – 23, 2023
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – Liver Disease

    Baylor College of Medicine – Houston, Texas, United States

    Associate Professor – Department of Cell and Molecular Biology

    University of Mississippi Medical Center – Jackson, Mississippi, United States

    Postdoctoral Fellow – Liver Diseases

    University of Illinois Chicago – Chicago, Illinois, United States

    Postdoctoral Fellow – Alcohol-Associated Liver Disease

    UNC-Greensboro – Kannapolis, North Carolina, United States

    Postdoctoral Associate – Cell Metabolism

    Baylor College of Medicine – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter